Sci Rep:在膀胱癌中,性别差异和死亡率到发生率与医疗卫生的差异有关

2017-07-01 AlexYang MedSci原创

在不同国家和不同性别之间死亡率到发生率(MIR)的变化反应了膀胱癌复杂的病因学和干预。最近,有研究人员就不同国家的不同性别和医疗卫生差异下,MIR的多样性情况进行了调查。癌症发生率和死亡率从GLOBOCAN 2012数据库中获得。从世界卫生组织中获得不同国家的医疗总花费级排名情况。并利用线性回归评估了变化的显著性。研究人员总共评估了33个国家的MIRs情况。研究人员发现,膀胱癌发生率和死亡率在更发

在不同国家和不同性别之间死亡率到发生率(MIR)的变化反应了膀胱癌复杂的病因学和干预。最近,有研究人员就不同国家的不同性别和医疗卫生差异下,MIR的多样性情况进行了调查。癌症发生率和死亡率从GLOBOCAN 2012数据库中获得。从世界卫生组织中获得不同国家的医疗总花费级排名情况。并利用线性回归评估了变化的显著性。研究人员总共评估了33个国家的MIRs情况。

研究人员发现,膀胱癌发生率和死亡率在更发达的地区、欧洲和美国较高,而MIRs在不发达的地区中更高。根据国家的分析表明,德国具有最低的MIR。另外,相对高的膀胱癌MIRs(女性MIR/男性MIR) 在许多发达国家中标注。不同国家之间的MIR和医疗卫生差异联系可以由世界卫生组织排名和在MIR和相对MIR上医疗卫生/GDP上的总花费显著的关系阐明。另外,更低的膀胱癌MIR在具有良好的医疗卫生系统的国家中表现突出。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1826366, encodeId=f7b51826366da, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Oct 11 19:52:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218555, encodeId=2371218555ee, content=看了原文摘要,文章的本意是比较膀胱癌的死亡率与发生率的比值,即死亡率/发生率的比值在不同国家之间的差异。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73f255205, createdName=ysburomas2003, createdTime=Tue Jul 04 17:01:13 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530900, encodeId=d22b1530900f8, content=<a href='/topic/show?id=4cd534866c9' target=_blank style='color:#2F92EE;'>#医疗卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34866, encryptionId=4cd534866c9, topicName=医疗卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ee212178304, createdName=wangtianj2011@, createdTime=Mon Jul 03 05:52:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217587, encodeId=3f9121e587cb, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sun Jul 02 00:33:23 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217493, encodeId=e16c21e493e7, content=学习了受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Jul 01 19:56:26 CST 2017, time=2017-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217444, encodeId=522c21e44426, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sat Jul 01 15:53:29 CST 2017, time=2017-07-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1826366, encodeId=f7b51826366da, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Oct 11 19:52:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218555, encodeId=2371218555ee, content=看了原文摘要,文章的本意是比较膀胱癌的死亡率与发生率的比值,即死亡率/发生率的比值在不同国家之间的差异。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73f255205, createdName=ysburomas2003, createdTime=Tue Jul 04 17:01:13 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530900, encodeId=d22b1530900f8, content=<a href='/topic/show?id=4cd534866c9' target=_blank style='color:#2F92EE;'>#医疗卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34866, encryptionId=4cd534866c9, topicName=医疗卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ee212178304, createdName=wangtianj2011@, createdTime=Mon Jul 03 05:52:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217587, encodeId=3f9121e587cb, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sun Jul 02 00:33:23 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217493, encodeId=e16c21e493e7, content=学习了受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Jul 01 19:56:26 CST 2017, time=2017-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217444, encodeId=522c21e44426, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sat Jul 01 15:53:29 CST 2017, time=2017-07-01, status=1, ipAttribution=)]
    2017-07-04 ysburomas2003

    看了原文摘要,文章的本意是比较膀胱癌的死亡率与发生率的比值,即死亡率/发生率的比值在不同国家之间的差异。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1826366, encodeId=f7b51826366da, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Oct 11 19:52:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218555, encodeId=2371218555ee, content=看了原文摘要,文章的本意是比较膀胱癌的死亡率与发生率的比值,即死亡率/发生率的比值在不同国家之间的差异。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73f255205, createdName=ysburomas2003, createdTime=Tue Jul 04 17:01:13 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530900, encodeId=d22b1530900f8, content=<a href='/topic/show?id=4cd534866c9' target=_blank style='color:#2F92EE;'>#医疗卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34866, encryptionId=4cd534866c9, topicName=医疗卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ee212178304, createdName=wangtianj2011@, createdTime=Mon Jul 03 05:52:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217587, encodeId=3f9121e587cb, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sun Jul 02 00:33:23 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217493, encodeId=e16c21e493e7, content=学习了受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Jul 01 19:56:26 CST 2017, time=2017-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217444, encodeId=522c21e44426, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sat Jul 01 15:53:29 CST 2017, time=2017-07-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1826366, encodeId=f7b51826366da, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Oct 11 19:52:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218555, encodeId=2371218555ee, content=看了原文摘要,文章的本意是比较膀胱癌的死亡率与发生率的比值,即死亡率/发生率的比值在不同国家之间的差异。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73f255205, createdName=ysburomas2003, createdTime=Tue Jul 04 17:01:13 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530900, encodeId=d22b1530900f8, content=<a href='/topic/show?id=4cd534866c9' target=_blank style='color:#2F92EE;'>#医疗卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34866, encryptionId=4cd534866c9, topicName=医疗卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ee212178304, createdName=wangtianj2011@, createdTime=Mon Jul 03 05:52:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217587, encodeId=3f9121e587cb, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sun Jul 02 00:33:23 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217493, encodeId=e16c21e493e7, content=学习了受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Jul 01 19:56:26 CST 2017, time=2017-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217444, encodeId=522c21e44426, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sat Jul 01 15:53:29 CST 2017, time=2017-07-01, status=1, ipAttribution=)]
    2017-07-02 189****7206

    学习了谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1826366, encodeId=f7b51826366da, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Oct 11 19:52:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218555, encodeId=2371218555ee, content=看了原文摘要,文章的本意是比较膀胱癌的死亡率与发生率的比值,即死亡率/发生率的比值在不同国家之间的差异。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73f255205, createdName=ysburomas2003, createdTime=Tue Jul 04 17:01:13 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530900, encodeId=d22b1530900f8, content=<a href='/topic/show?id=4cd534866c9' target=_blank style='color:#2F92EE;'>#医疗卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34866, encryptionId=4cd534866c9, topicName=医疗卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ee212178304, createdName=wangtianj2011@, createdTime=Mon Jul 03 05:52:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217587, encodeId=3f9121e587cb, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sun Jul 02 00:33:23 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217493, encodeId=e16c21e493e7, content=学习了受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Jul 01 19:56:26 CST 2017, time=2017-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217444, encodeId=522c21e44426, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sat Jul 01 15:53:29 CST 2017, time=2017-07-01, status=1, ipAttribution=)]
    2017-07-01 131****1460

    学习了受益匪浅。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1826366, encodeId=f7b51826366da, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Oct 11 19:52:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218555, encodeId=2371218555ee, content=看了原文摘要,文章的本意是比较膀胱癌的死亡率与发生率的比值,即死亡率/发生率的比值在不同国家之间的差异。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73f255205, createdName=ysburomas2003, createdTime=Tue Jul 04 17:01:13 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530900, encodeId=d22b1530900f8, content=<a href='/topic/show?id=4cd534866c9' target=_blank style='color:#2F92EE;'>#医疗卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34866, encryptionId=4cd534866c9, topicName=医疗卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ee212178304, createdName=wangtianj2011@, createdTime=Mon Jul 03 05:52:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217587, encodeId=3f9121e587cb, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sun Jul 02 00:33:23 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217493, encodeId=e16c21e493e7, content=学习了受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat Jul 01 19:56:26 CST 2017, time=2017-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217444, encodeId=522c21e44426, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sat Jul 01 15:53:29 CST 2017, time=2017-07-01, status=1, ipAttribution=)]
    2017-07-01 1e145228m78(暂无匿称)

    学习了,谢谢作者分享!

    0

相关资讯

J Urol:根治性膀胱切除术前双J管引流增加上尿路复发风险

伴有肾盂积水的膀胱癌患者在接受进一步治疗之前,往往需要引流受影响的肾脏。导管可选择逆行置入或经皮顺行置入。然而,逆行支架置入术有使肿瘤细胞溢出到上泌尿道的风险。本研究的目的是评估膀胱癌患者在行根治性膀胱切除术之前如果行逆行支架置入术是会否增加上尿路复发风险。

Sci Rep:非肌肉侵入性膀胱癌的系统回顾与丝裂霉素C和卡介苗(BCG)累积分析

最近,有研究人员进行了系统回顾和累积分析,旨在探索膀胱内注射丝裂霉素C(MMC)和卡介苗(BCG)组合使用对非肌肉侵入性膀胱癌(NMIBC)的治疗效果和安全性情况。研究人员进行了综合性的文献搜索,比如利用Pubmed、 Embase、 Medline、 Cochrane Library,、CBM,和CNKI数据库,并且使用了VIP数据库来鉴定截止到2016年6月,利用膀胱内注射丝裂霉素C和卡介苗疗

Cancer Epidem:一有时间就坐在沙发上面看电视的人,可能会面临肾癌和膀胱癌的风险

一项新的研究表明,长时间的坐在沙发上对你的健康不利,会增加患肾癌和膀胱癌的风险。

Diabetes Obes Metab:老年2型糖尿病患者采用吡格列酮与其他治疗发生膀胱癌的风险比较!

由此可见,吡格列酮治疗与膀胱癌风险升高相关,相比于DPP-4s和磺脲类药物。升高的风险发生在治疗前2年内,并在停药后有所减弱。吡格列酮的相对有效性应与较小的膀胱癌风险绝对增加相权衡。

Environ. Health Perspect:消毒水(饮用,淋浴,游泳池)副产物暴露与膀胱癌之间的关系研究。

目前已有多项研究表明消毒副产物的摄入与膀胱癌之间存在联系。尽管与多种暴露途径的关联已经被提出了,但流行病学证据依然有限。

PLoS One:体力活动水平与寿命及前列腺癌和膀胱癌之间关系的探究

最近的荟萃分析表明高体力活动水平对前列腺癌和膀胱癌的发展有适度的保护作用,但这些研究分析中存在显着的异质性。研究者意识到,在中国很少有研究调查体力活动与前列腺癌和膀胱癌之间的关联。鉴于以往研究的不一致性,以及体力活动与前列腺癌和膀胱癌之间的关系研究在中国的稀缺性,体力活动与前列腺癌和膀胱癌之间的联系仍然难以确定。